BRIDGEBIO PHARMA INC

Ticker: BBIO CUSIP: 10806X102 Class: EQTY

Brevan Howard Capital Management LP's Holding History (CIK: 0001512857)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 173,523 Value ($000) $13,176 Avg Close $65.64 Range $51.85 - $78.44

Q3 2025

Shares 52,418 Value ($000) $2,723 Avg Close $48.77 Range $41.80 - $54.60

Q2 2025

Shares 104,110 Value ($000) $4,495 Avg Close $36.37 Range $28.32 - $45.48

Q4 2024

Shares 14,760 Value ($000) $405 Avg Close $25.84 Range $21.72 - $30.51

Q3 2024

Shares 24,482 Value ($000) $623 Avg Close $26.25 Range $23.40 - $32.06

Q2 2024

Shares 13,185 Value ($000) $334 Avg Close $27.34 Range $21.62 - $31.43

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	173,523	$13,176	$65.64	$51.85 - $78.44
Q3 2025	52,418	$2,723	$48.77	$41.80 - $54.60
Q2 2025	104,110	$4,495	$36.37	$28.32 - $45.48
Q4 2024	14,760	$405	$25.84	$21.72 - $30.51
Q3 2024	24,482	$623	$26.25	$23.40 - $32.06
Q2 2024	13,185	$334	$27.34	$21.62 - $31.43